Clinical Trials on CD20 Positive Non Hodgkin Lymphoma
Total 5742 results
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced NeutropeniaGermany, Italy, Spain
-
Eric Bernicker, MDMillennium Pharmaceuticals, Inc.; The Methodist Hospital Research InstituteWithdrawnCD30-positive Lymphoma | CD30-positive Solid TumorUnited States
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Australia
-
PrECOG, LLC.Genentech, Inc.CompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma Follicular | Non-Hodgkin's Lymphoma, Adult High GradeUnited States
-
Cellectis S.A.RecruitingB-cell Non-Hodgkin Lymphoma (B-NHL)United States, Spain, France
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
University of CologneNovartisTerminated
-
The First Affiliated Hospital of Soochow UniversityEnrolling by invitationRelapsed or Refractory B-cell Non-Hodgkin LymphomaChina
-
Masonic Cancer Center, University of MinnesotaCompletedDiffuse Large B Cell Non-Hodgkin LymphomaUnited States
-
Genentech, Inc.Completed
-
Sheba Medical CenterCompletedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Autologous Stem Cell Transplantation | Stem Cell MobilizationIsrael
-
Czech Lymphoma Study GroupRecruitingNon Hodgkin Lymphoma (NHL)Czechia
-
Juventas Cell Therapy Ltd.CompletedDiffuse Non-Hodgkin LymphomaChina
-
Gruppo Italiano Studio LinfomiUnknown
-
Stanford UniversityTerminatedPrimary Myelofibrosis | Myelofibrosis | Recurrent Adult Acute Myeloid Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Refractory Non-Hodgkin Lymphoma | Blast... and other conditionsUnited States
-
National Cancer Institute (NCI)Enrolling by invitationAcute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Non-Hodgkins Lymphoma | Myelodysplastic Syndrome (MDS) | Hodgkins LymphomaUnited States
-
Affiliated Hospital of Nantong UniversityNot yet recruiting
-
Austin HealthMerck KGaA, Darmstadt, GermanyActive, not recruitingLymphomas Non-Hodgkin's B-CellAustralia
-
Cho Pharma Inc.RecruitingNon-Hodgkin LymphomaTaiwan, United States
-
Abramson Cancer Center at Penn MedicineRecruitingNon Hodgkin LymphomaUnited States
-
Artiva Biotherapeutics, Inc.RecruitingNon Hodgkin LymphomaUnited States
-
University of Texas Southwestern Medical CenterRecruiting
-
Ruijin HospitalRecruitingNon Hodgkin LymphomaChina
-
Chinese PLA General HospitalRecruitingNon Hodgkin LymphomaChina
-
Zentera Therapeutics HK LimitedTerminated
-
Hoffmann-La RocheCompletedNon-Hodgkin LymphomaAlgeria, Morocco, Tunisia
-
Rhizen Pharmaceuticals SACompletedNon Hodgkin LymphomaUnited States, Australia
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedNon-Hodgkin LymphomaUnited States
-
Soonchunhyang University HospitalCompletedNon-hodgkin LymphomaKorea, Republic of
-
BayerCompleted
-
Sidney Kimmel Cancer Center at Thomas Jefferson...TerminatedNon-Hodgkin LymphomaUnited States
-
University Hospital TuebingenCompleted
-
University Hospital TuebingenCompletedNon-Hodgkin LymphomaGermany
-
Gruppo Italiano Multiregionale per lo studio dei...University of Turin, Italy; Fondazione Italiana Linfomi ONLUS; Centro di Riferimento...CompletedLymphoma | Non-Hodgkin LymphomaItaly
-
Jennifer AmengualCompletedLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Roswell Park Cancer InstituteNovartisTerminatedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States
-
Adagene (Suzhou) LimitedTerminatedSolid Tumor | Non Hodgkin LymphomaChina
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Solid NeoplasmUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHodgkin Lymphoma | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | AML | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloproliferative Disorder | ALL | Non-malignant Diseases Requiring Allogeneic HSCTUnited States
-
Case Comprehensive Cancer CenterActive, not recruitingNon-hodgkin LymphomaUnited States
-
Benjamin TomlinsonActive, not recruitingNon-Hodgkin LymphomaUnited States
-
New York Medical CollegeCompletedNon Hodgkin Lymphoma
-
AstraZenecaTerminatedNon-Hodgkin LymphomaSpain, United States, Korea, Republic of, France, Portugal, Australia, Italy
-
Teva Branded Pharmaceutical Products R&D, Inc.Completed
-
Tahir LatifActive, not recruitingNon Hodgkin LymphomaUnited States
-
Spectrum Pharmaceuticals, IncThe Leukemia and Lymphoma SocietyTerminated
-
ImmunityBio, Inc.Withdrawn
-
Timmune Biotech Inc.Unknown
-
Alberta Health Services, CalgaryUnknownNon-Hodgkin LymphomaCanada